Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Soluble ST2 predicts outcome and hemorrhagic transformation after acute stroke.
Wolcott Z, Batra A, Bevers MB, Sastre C, Khoury J, Sperling M, Meyer BC, Walsh KB, Adeoye O, Broderick JP, Kimberly WT. Wolcott Z, et al. Among authors: meyer bc. Ann Clin Transl Neurol. 2017 Jul 5;4(8):553-563. doi: 10.1002/acn3.435. eCollection 2017 Aug. Ann Clin Transl Neurol. 2017. PMID: 28812045 Free PMC article.
Review, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria: Part 1: rapidly improving stroke symptoms.
Re-examining Acute Eligibility for Thrombolysis (TREAT) Task Force:; Levine SR, Khatri P, Broderick JP, Grotta JC, Kasner SE, Kim D, Meyer BC, Panagos P, Romano J, Scott P; NINDS rt-PA Stroke Trial Investigators. Re-examining Acute Eligibility for Thrombolysis (TREAT) Task Force:, et al. Among authors: meyer bc. Stroke. 2013 Sep;44(9):2500-5. doi: 10.1161/STROKEAHA.113.000878. Epub 2013 Jul 11. Stroke. 2013. PMID: 23847249 Free PMC article. Review.
Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial.
Pancioli AM, Adeoye O, Schmit PA, Khoury J, Levine SR, Tomsick TA, Sucharew H, Brooks CE, Crocco TJ, Gutmann L, Hemmen TM, Kasner SE, Kleindorfer D, Knight WA, Martini S, McKinney JS, Meurer WJ, Meyer BC, Schneider A, Scott PA, Starkman S, Warach S, Broderick JP; CLEAR-ER Investigators. Pancioli AM, et al. Among authors: meyer bc. Stroke. 2013 Sep;44(9):2381-7. doi: 10.1161/STROKEAHA.113.001059. Epub 2013 Jul 25. Stroke. 2013. PMID: 23887841 Free PMC article. Clinical Trial.
Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging.
Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, McTaggart RA, Torbey MT, Kim-Tenser M, Leslie-Mazwi T, Sarraj A, Kasner SE, Ansari SA, Yeatts SD, Hamilton S, Mlynash M, Heit JJ, Zaharchuk G, Kim S, Carrozzella J, Palesch YY, Demchuk AM, Bammer R, Lavori PW, Broderick JP, Lansberg MG; DEFUSE 3 Investigators. Albers GW, et al. N Engl J Med. 2018 Feb 22;378(8):708-718. doi: 10.1056/NEJMoa1713973. Epub 2018 Jan 24. N Engl J Med. 2018. PMID: 29364767 Free PMC article. Clinical Trial.
To Treat or Not to Treat?
Levine SR, Weingast SZ, Weedon J, Stefanov DG, Katz P, Hurley D, Kasner SE, Khatri P, Broderick JP, Grotta JC, Feldmann E, Panagos PD, Romano JG, Bianchi R, Meyer BC, Scott PA, Kim D, Balucani C. Levine SR, et al. Among authors: meyer bc. Stroke. 2018 Aug;49(8):1933-1938. doi: 10.1161/STROKEAHA.118.020971. Stroke. 2018. PMID: 29976582
The Utility of Domain-Specific End Points in Acute Stroke Trials.
Cramer SC, Wolf SL, Saver JL, Johnston KC, Mocco J, Lansberg MG, Savitz SI, Liebeskind DS, Smith W, Wintermark M, Elm JJ, Khatri P, Broderick JP, Janis S; NIH StrokeNet Recovery and Rehabilitation Group and the Acute Stroke Group*. Cramer SC, et al. Stroke. 2021 Mar;52(3):1154-1161. doi: 10.1161/STROKEAHA.120.031939. Epub 2021 Feb 10. Stroke. 2021. PMID: 33563009 Free PMC article. Review.
Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection.
Albers GW, Jumaa M, Purdon B, Zaidi SF, Streib C, Shuaib A, Sangha N, Kim M, Froehler MT, Schwartz NE, Clark WM, Kircher CE, Yang M, Massaro L, Lu XY, Rippon GA, Broderick JP, Butcher K, Lansberg MG, Liebeskind DS, Nouh A, Schwamm LH, Campbell BCV; TIMELESS Investigators. Albers GW, et al. N Engl J Med. 2024 Feb 22;390(8):701-711. doi: 10.1056/NEJMoa2310392. Epub 2024 Feb 8. N Engl J Med. 2024. PMID: 38329148 Clinical Trial.
Can comprehensive stroke centers erase the 'weekend effect'?
Albright KC, Raman R, Ernstrom K, Hallevi H, Martin-Schild S, Meyer BC, Meyer DM, Morales MM, Grotta JC, Lyden PD, Savitz SI. Albright KC, et al. Among authors: meyer bc, meyer dm. Cerebrovasc Dis. 2009;27(2):107-13. doi: 10.1159/000177916. Epub 2008 Nov 28. Cerebrovasc Dis. 2009. PMID: 19039213 Free PMC article.
237 results